★ Free consultation on every service — no commitment, no card required. Book now
$399/month · Free consult Zepbound · Vial · Tirzepatide

Zepbound vial — the lower-cost FDA-approved tirzepatide format

In 2024, Lilly launched the Zepbound vial format as a self-pay alternative to the KwikPen — same FDA-approved tirzepatide, lower price, vial-and-syringe delivery. For members who don't need the auto-injector format and want brand Zepbound at a better price, this is the path.

ActiveTirzepatide (brand)
FormatSingle-dose vial + syringe
Doses2.5 / 5 / 7.5 / 10 / 12.5 / 15 mg
Best forCost-conscious brand seekers
— Overview

Why the vial format exists

Brand tirzepatide for less — Lilly's response to the compounded tirzepatide market.

In late 2024, Eli Lilly introduced the Zepbound vial format — the same FDA-approved tirzepatide molecule as the KwikPen, but in a single-dose glass vial that you draw into a separate syringe. The vial format launched at a substantially lower cash-pay price than the KwikPen, positioning it as a direct competitive option to compounded tirzepatide.

For the right member, this is a meaningful win. You get brand-name FDA approval (which matters for some insurance contexts and personal preference), the full SURMOUNT trial efficacy data, the new sleep apnea indication, and Lilly's manufacturing quality — at a price that's competitive with compounded options.

What you trade off compared to the KwikPen: a slightly more involved injection process. You draw the dose from the vial into a syringe, expel air, and self-inject. For members who already inject medications (other GLP-1, insulin, fertility, immunotherapy), this is routine. For first-time injectors, the KwikPen format is gentler.

HealifyNow prescribes Zepbound vials for members who want brand-name FDA-approved tirzepatide at a lower price point than the KwikPen. The $399/month program includes monthly clinician visits, medication supply, and ongoing follow-up. The free initial consultation determines which format best fits you.

— Who it's for

Who fits the vial format

💵

Want brand at lower cost

The vial format is Lilly's cash-pay alternative to the KwikPen at a meaningfully lower price.

🩹

Comfortable with self-injection

Drawing from a vial and injecting with a separate syringe is straightforward — but it's a step beyond auto-injector ease.

🎯

Same efficacy as KwikPen

Same molecule, same FDA approval, same SURMOUNT trial data, same mechanism. The format doesn't change the medication.

🏠

Brand-name preference

Some members specifically want brand Zepbound for FDA-traceable manufacturing rather than compounded.

— Process

How HealifyNow makes it simple

From your first message to your medication arriving at your door — clinician-guided, every step.

1

Schedule your free visit

A care team member meets with you to understand your goals, medical history, and treatment preferences. The first visit is no-cost and no-commitment — we want you to be confident before moving forward.

2

Meet your licensed clinician

Connect by secure video or phone with a U.S.-licensed physician or nurse practitioner who reviews your full picture — labs, prior treatments, current medications, and lifestyle — and decides what is clinically appropriate.

3

Receive your prescription if appropriate

If your clinician determines treatment is right for you, they issue a prescription that goes to a licensed U.S. pharmacy. We coordinate discreet shipping, or you can fill it locally. Follow-up visits are built in.

— Mechanism

How tirzepatide works

Tirzepatide is the same molecule whether delivered via KwikPen or vial. It activates two incretin receptors:

GLP-1 receptor activation — same mechanism as semaglutide. Appetite suppression in the hypothalamus, slowed gastric emptying, glucose-dependent insulin release, glucagon suppression.

GIP receptor activation — distinct from GLP-1. Improves insulin sensitivity, increases fat oxidation (lipolysis), and adds weight-loss effect that semaglutide alone doesn't produce.

The dual mechanism is why tirzepatide outperformed semaglutide in head-to-head trials (SURMOUNT-5, late 2024). At maximum doses, tirzepatide produced approximately 20% body weight loss versus approximately 14% for semaglutide at 72 weeks.

The 2024 FDA approval for obstructive sleep apnea (based on SURMOUNT-OSA) made Zepbound the first medication approved for OSA. Many members on Zepbound reduce or eliminate CPAP need with treatment.

— Safety

Important safety information

Your clinician will review every relevant detail with you. Here are the most important points to know up front.

GI side effects during titration

Nausea and constipation are most common during dose increases. Slow titration is key.

Thyroid cancer warning

Personal or family history of MTC or MEN2 contraindicates.

Pregnancy contraindication

Discontinue 2 months before planned conception.

Vial handling

Use the supplied syringes, follow draw-up protocol, dispose of needles properly. Your care team trains you.

Important

All medications must be prescribed by a licensed provider based on medical necessity. Treatment is not suitable for everyone. Results may vary.

— Use

How to use the Zepbound vial

What you receive. Single-dose glass vials (one per weekly dose) plus disposable syringes, alcohol wipes, and a sharps container. Your care team includes a written guide and a brief video for the first injection.

Drawing the dose. Wipe the vial top with alcohol. Pull the syringe plunger to the dose mark, insert the needle, push air into the vial, invert, and draw the dose. Tap any air bubbles to the top and gently push them out. Total time once practiced: 30-60 seconds.

The injection. Same as any subcutaneous injection — abdomen, thigh, or upper arm. Pinch a small fold of skin, insert the needle at 90 degrees, push the plunger steadily, withdraw. Dispose of the syringe in your sharps container.

Storage. Refrigerate unused vials. Once a vial is in use, it can stay at room temperature briefly during the injection then return to the fridge if multi-use. Single-use vials are simply disposed after the injection.

Dose titration. Same schedule as KwikPen: 2.5 mg for 4 weeks, then 5 mg, with 2.5 mg increases every 4 weeks based on tolerance and response, up to 15 mg maximum.

— Tool

Quick eligibility tool

Get a fast read on whether this is worth a deeper conversation.

Check your BMI eligibility in 5 seconds

GLP-1 medications are typically appropriate for adults with BMI ≥ 30, or ≥ 27 with a related condition. This is not medical advice — a clinician will evaluate you fully.

120k+

Patients served across the U.S.

96%

Member satisfaction with care team

4.8★

Average review rating

3 days

From visit to medication shipment

— Why us

Why patients choose HealifyNow

We built HealifyNow because telehealth done badly is everywhere — and telehealth done right still feels rare. Here is what makes us different.

Easy Online Process

No waiting rooms, no faxed forms, no insurance hoops. Quick consults, simple intake, prescriptions handled digitally.

U.S.-Licensed Clinicians

Real physicians, nurse practitioners, and specialists licensed in your state. Not chatbots, not offshore call centers.

Discreet Home Delivery

Medications ship from licensed U.S. pharmacies in plain packaging. Most orders arrive in 2-5 business days.

Support That Answers

Reach a real human seven days a week. Most messages get a clinical reply within a few hours, not days.

— Care team

Real U.S.-licensed clinicians

Every prescription on HealifyNow is reviewed and authorized by an independently licensed physician or nurse practitioner. No bots, no shortcuts.

🩺

Board-Certified Physician

Internal Medicine

Board-certified internal medicine physicians on our care team provide evidence-based evaluations for weight management, metabolic health, and longevity care. Every patient is reviewed individually with treatment recommendations based on clinical need.

💚

Family Nurse Practitioner

Hormone & Wellness

Family nurse practitioners with 10+ years of telehealth experience handle hormone optimization, perimenopause care, and wellness protocols. Care is patient-centered and grounded in current evidence.

🩺

Board-Certified Physician

Endocrinology Focus

Endocrinology-trained physicians review every member with insulin resistance, PCOS, thyroid issues, or complex metabolic patterns. Treatment decisions are based on labs, history, and your goals.

🧠

Licensed Mental Health Clinician

Psychiatric Evaluations

Licensed psychologists, LCSWs, LMFTs, and psychiatric NPs across all 50 states handle ESA and PSD evaluations alongside anxiety and depression care. Real evaluation, never rubber-stamping.

— Stories

What members are saying

Real people, real results. Names and details published with permission.

★★★★★

"Tried compounded tirzepatide for 6 months — worked fine. When Lilly released the vial format, I switched for the FDA-brand assurance at a similar price. Same results, more confidence about supply chain."

AK
Andrew K., 44
Houston, TX · Zepbound vial · 5 months
★★★★★

"I already inject insulin daily. The vial format isn't intimidating to me. Saved money over the KwikPen and got brand Zepbound. 26 lbs down in 4 months."

YT
Yvette T., 57
Cleveland, OH · Zepbound vial · 4 months
★★★★★

"Lilly's vial launch was the answer I was waiting for. Wanted brand-name FDA approval without the KwikPen premium. Care team trained me on draw-up over video. Routine now."

BN
Brian N., 49
San Diego, CA · Zepbound vial · 7 months
— FAQ

Frequently asked questions

HealifyNow makes it easy to move forward with confidence. Here are the answers to what people ask us most.

How much cheaper is the vial than the KwikPen?

+

Lilly launched the vials at a substantially lower cash-pay price than the KwikPen. Through HealifyNow's program, the vial format is $399/month inclusive — competitive with compounded tirzepatide.

Is the vial the same medication as the KwikPen?

+

Yes. Same tirzepatide molecule, same FDA approval, same dose strengths, same efficacy. Only the delivery format differs.

Is the vial harder to use than the KwikPen?

+

It's a few extra steps — draw, expel air, inject — versus the KwikPen's one-click design. Members who've injected before (insulin, fertility meds, other GLP-1) usually find it easy. First-time injectors often prefer the KwikPen.

Can I use the same syringe twice?

+

No. Syringes are single-use. We provide enough syringes for each weekly dose and a sharps container for disposal.

Does insurance cover the Zepbound vial?

+

Mixed coverage — some commercial insurance covers Zepbound for weight management with prior authorization (the vial and KwikPen are coded the same way). Medicare typically doesn't cover weight-loss medications. We help check.

Can I switch from the vial to the KwikPen or vice versa?

+

Yes — same medication. Many members switch formats based on travel needs (KwikPens easier to bring on trips) or cost considerations.

What's the difference between this and compounded tirzepatide?

+

Brand Zepbound (vial or KwikPen) is manufactured by Lilly under FDA approval and oversight. Compounded tirzepatide is produced by licensed U.S. 503A and 503B compounding pharmacies — same active molecule, different manufacturing pathway and regulatory framework.

How long does each vial last?

+

Each vial is single-use, containing one weekly dose. You receive one vial per week of your dose strength.

Get brand Zepbound at a better price.

Book a free consultation. We'll help you choose between the vial and KwikPen based on your situation.